82110-21-2

Basic information

• Product Name: (S)-2-Methyltetrahydropyran-4-one
• Synonyms: (S)-2-Methyltetrahydropyran-4-one;(2S)-2-methyloxan-4-one;4H-Pyran-4-one, tetrahydro-2-methyl-, (S)-;4H-Pyran-4-one, tetrahydro-2-methyl-, (2S)-
• CAS NO: 82110-21-2
• Molecular Formula: C₆H₁₀O₂
• Molecular Weight: 114.1424
• Mol File: 82110-21-2.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (S)-2-Methyltetrahydropyran-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-2-Methyltetrahydropyran-4-one(82110-21-2)
• EPA Substance Registry System: (S)-2-Methyltetrahydropyran-4-one(82110-21-2)

Safety Data

• Hazardous Substances Data: 82110-21-2(Hazardous Substances Data)

Usage

General Description

(S)-2-Methyltetrahydropyran-4-one, also known as S-Methyl-γ-butyrolactone, is a chemical compound with a molecular formula of C6H10O2. It is a colorless liquid with a fruity odor that is commonly used as a flavoring agent in the food industry. (S)-2-Methyltetrahydropyran-4-one is also known to possess sedative and anesthetic properties, making it an interesting target for pharmaceutical applications. Additionally, (S)-2-Methyltetrahydropyran-4-one is a key intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its unique chemical structure and properties make it a versatile compound with a wide range of potential uses.

Upstream product

• 1202377-93-2 (S)-7-methyl-1,4,8-trioxaspiro[4.5]decane 
• 190912-15-3 (2S)-2-methyl-2,3-dihydropyran-4-one 
• 548440-36-4 (S)-5-((tert-butyldimethylsilyl)oxy)hex-1-en-3-one 
• 548440-42-2 (S)-5-(triethylsilyloxy)hex-1-en-3-one 
• 133813-41-9 (2S,4S)-2,4-dihydroxyhept-6-ene 
• 81076-06-4 (2S,3R,4S)-(-)-2,3-Epoxy-6-hepten-4-ol 
• 24581-03-1 (5E)-hepta-1,5-dien-4-ol 
• 89791-47-9 (2S,4S)-4-hydroxy-2-methyltetrahydropyran 
• 82110-13-2 (2S,4S)-4-hydroxy-2-methyl-3,4,5,6-tetrahydro-2H-pyran 
• 1193-20-0 2-methyltetrahydro-4H-pyran-4-one 

Downstream Products

• 146565-13-1 (2S,4S)-4-<3-(benzyloxy)-5-fluorophenyl>-4-methoxy-2-methyl-3,4,5,6-tetrahydro-2H-pyran 
• 133813-44-2 (2S,4R)-4-<3-(benzyloxy)-5-fluorophenyl>-4-methoxy-2-methyl-3,4,5,6-tetrahydro-2H-pyran 
• 135715-91-2 (2S,4R)-4-(3-bromophenyl)-4-methoxy-2-methyltetrahydropyran 
• 133813-38-4 C₁₉H₂₂O₃ 
• 406463-50-1 (2S,4S)-4-hydroxy-2-methyl-4-[2-(1-methyl-2-oxoindolin-5-ylthio)thien-4-yl]-tetrahydropyran 
• 166882-70-8 5-[[4-[(2S,4R)-4-hydroxy-2-methyl-tetrahydropyran-4-yl]-2-thienyl]sulfanyl]-1-methyl-indolin-2-one 
• 146565-10-8 (2S,4S)-4-(3-benzyloxy-5-fluorophenyl)-4-hydroxy-2-methyltetrahydropyran 
• 146565-11-9 (2S,4R)-4-(3-Benzyloxy-5-fluoro-phenyl)-2-methyl-tetrahydro-pyran-4-ol 

Relevant articles and documents

Discovery of MK-6169, a Potent Pan-Genotype Hepatitis C Virus NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Substitutions

We describe the discovery of MK-6169, a potent and pan-genotype hepatitis C virus NS5A inhibitor with optimized activity against common resistance-associated substitutions. SAR studies around the combination of changes to both the valine and aminal carbon region of elbasvir led to the discovery of a series of compounds with substantially improved potency against common resistance-associated substitutions in the major genotypes, as well as good pharmacokinetics in both rat and dog. Through further optimization of key leads from this effort, MK-6169 (21) was discovered as a preclinical candidate for further development.

TRICYCLIC INHIBITORS OF 5-LIPOXYGENASE

Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of 5-lipoxygenase (5-LO). Also described herein are methods of using such 5-LO inhibitors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions, diseases, or disorders.

5-lipoxygenase inhibitors quinoxalinyl derivatives

The invention concerns a heterocyclic derivative of the formula I STR1 wherein Q is an optionally substituted quinoxalinyl or a hydrogenated derivative thereof X1 is oxy, thio, sulphinyl, sulphonyl or imino; Ar is phenylene which may optionally bear one or two substituents or Ar is an optionally substituted 6-membered heterocyclene moiety containing up to three nitrogen atoms; R1 is (1-6C)alkyl, (3-6C)alkenyl or (3-6C)alkynyl; and R2 and R3 together form a group of the formula --A2 --X2 --A3 -- which, together with the carbon atom to which A2 and A3 are attached, defines a ring having 4 to 7 ring atoms, wherein A2 and A3, which may be the same or different, each is (1-4C)alkylene and X2 is oxy, thio, sulphinyl, sulphonyl or imino; or a pharmaceutically-acceptable salt thereof. The compounds of the invention are inhibitors of the enzyme 5-lipoxygenase.